SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-22-053860
Filing Date
2022-05-02
Accepted
2022-04-29 17:38:27
Documents
2
Group Members
ALEC N. LITOWITZMAGNETAR CAPITAL PARTNERS LPSUPERNOVA MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2214084d1_sc13d.htm SC 13D 123214
2 EXHIBIT 99.1 tm2214084d1_ex99-1.htm EX-99.1 7711
  Complete submission text file 0001104659-22-053860.txt   132855
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Subject) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-47575 | Film No.: 22877915
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 1603 ORRINGTON AVE. 13TH FLOOR EVANSTON IL 60201
Business Address 1603 ORRINGTON AVE. 13TH FLOOR EVANSTON IL 60201 (847)905-4400
Magnetar Financial LLC (Filed by) CIK: 0001352851 (see all company filings)

IRS No.: 043818748 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D